Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MONDRIAN: Multi-omics Integrative Modelling for Stereotactic Body Radiotherapy in Early-stage Non-small Cell Lung Cancer

NCT05974475 is registered in ClinicalTrials.gov with European Institute of Oncology as lead sponsor.

NCT NCT05974475
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05974475 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MONDRIAN: Multi-omics Integrative Modelling for Stereotactic Body Radiotherapy in Early-stage Non-small Cell Lung Cancer
Lead sponsor
European Institute of Oncology
Phase
Observational
Overall status
Recruiting
Start date
September 11, 2023
Completion date
September 30, 2028
Enrollment
270 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

lung neoplasm malignant